Market Forecast Report on Parasitic Diseases Therapeutic 2019-2025 - Jewish Life News

Market Forecast Report on Parasitic Diseases Therapeutic 2019-2025 - Jewish Life News


Market Forecast Report on Parasitic Diseases Therapeutic 2019-2025 - Jewish Life News

Posted: 30 Mar 2020 06:04 AM PDT

The global Parasitic Diseases Therapeutic market reached ~US$ xx Mn in 2019 and is anticipated grow at a CAGR of xx% over the forecast period 2019-2029. In this Parasitic Diseases Therapeutic market study, the following years are considered to predict the market footprint:

  • History Year: 2014 – 2018
  • Base Year: 2019
  • Estimated Year: 2019
  • Forecast Year: 2019 – 2029

The business intelligence study of the Parasitic Diseases Therapeutic market covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). In a bid to recognize the growth prospects in the Parasitic Diseases Therapeutic market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market. Each segment of the Parasitic Diseases Therapeutic market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the Global regions.

Each market player encompassed in the Parasitic Diseases Therapeutic market study is assessed according to its market share, production footprint, current launches, agreements, ongoing R&D projects, and business tactics. In addition, the Parasitic Diseases Therapeutic market study scrutinizes the strengths, weaknesses, opportunities and threats (SWOT) analysis.

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2443972&source=atm

The key players covered in this study
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Sanaria

Market segment by Type, the product can be split into
Peptides Medicine
Insect Repellent
Acaricide
Other

Market segment by Application, split into
Commercial
Household

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Parasitic Diseases Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Parasitic Diseases Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Parasitic Diseases Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Make An Enquiry About This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2443972&source=atm 

What insights readers can gather from the Parasitic Diseases Therapeutic market report?

  • A critical study of the Parasitic Diseases Therapeutic market on the basis of segment 1, segment 2 and segment 3.
  • Learn the behavior pattern of every Parasitic Diseases Therapeutic market player – product launches, expansions, collaborations and acquisitions in the market currently.
  • Examine and study the progress outlook of the global Parasitic Diseases Therapeutic landscape, which includes, revenue, production & consumption and historical & forecast.
  • Understand important drivers, restraints, opportunities, and trends (DROT Analysis).
  • Important trends, such as carbon footprint, R&D developments, prototype technologies, and globalization.

The Parasitic Diseases Therapeutic market report answers the following queries:

  1. Which players hold the significant Parasitic Diseases Therapeutic market share and why?
  2. What strategies are the Parasitic Diseases Therapeutic market players forming to gain a competitive edge?
  3. Why region is expected to lead the global Parasitic Diseases Therapeutic market?
  4. What factors are negatively affecting the Parasitic Diseases Therapeutic market growth?
  5. What will be the value of the global Parasitic Diseases Therapeutic market by the end of 2029?

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2443972&licType=S&source=atm 

Why Choose Parasitic Diseases Therapeutic Market Report?

  1. Deliver updated information on the current industry trends
  2. Available 24/7 to facilitate clients with unbiased solutions
  3. Embrace digital technologies to offer accurate business ideas
  4. Exhaustive supply chain augmentation analysis
  5. Provide reports strictly according to the requirements of the clients

For More Information Kindly Contact:

ResearchMoz.com

Mr. Nachiket Ghumare,

90 State Street,

Albany NY,

United States – 12207

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [email protected]

IPK, Cuba's command center › Cuba › Granma - Official voice of the PCC - Granma English

Posted: 30 Mar 2020 09:42 AM PDT

Biosecurity protocols developed by the IPK are among its key contributions in work with infectious diseases. Photo: Ariel Cecilio Lemus Alvarez

With the fundamental mission of controlling, preventing and treating infectious diseases that affect the Cuban population, the Pedro Kourí Institute of Tropical Medicine (IPK) is currently functioning as Cuba's command center in the Public Health system's battle to develop prevention and training strategies to confront the global threat of the new SARS COV-2 coronavirus.

The institution's National Reference Laboratory, of international prestige, is one of the three responsible for confirming cases of Covid-19, the disease resulting from this dangerous virus.

According to Dr. Manuel Romero Placeres, director of the institution - which is home to national reference centers for viral, bacterial, parasitic and mycological diseases, including HIV/AIDS - the symptoms that may indicate Covid-19 are fever, cough, runny nose, sore throat and general malaise, similar to other common types of flu, and said the elderly population is most likely to develop severe symptoms and complications after contracting the infection.

Dr. Eric Martínez Torres, a pediatric specialist at the center with extensive experience in this type of disease, said that, in general, children are the age group least likely to become infected.

This particularity, he said, yet to be well studied, has been noted in the current Covid-19 outbreak, as well as those of other previously seen coronaviruses.

He reported that dozens of beds have are available to receive infected patients, some of which are designated for pregnant women and children.

"The entire staff has been trained, both at the institute and in other Cuban facilities involved in this battle."

Dr. Placeres explained that the protocol followed with individuals who exhibit symptoms associated with Covid-19, arriving at ports, airports, marinas and hospitals in the country, mandates their immediate transfer to isolation centers identified by health authorities in the different territories. Confirmed cases are later referred to reference hospitals in each region.

He noted that the IPK is caring for patients with the disease, as well as those admitted for surveillance.

Laboratories of the Provincial Centre of Hygiene, Epidemiology and Microbiology of Villa Clara and Santiago de Cuba have also been trained to conduct tests to confirm the virus's presence.

These two provinces, he said, receive samples from the central and eastern regions of the country, respectively, while the IPK has this responsibility in the west, in addition to serving as a reference for the others. "The laboratories are well equipped and have the necessary means for diagnosing the disease, which have been provided by Ministry and the Pan-American Health Organization."

Regarding the handling of samples, consisting of a nasal and pharyngeal exudate, the doctor noted that these are transported according to established biosafety protocols, protected in triple packaging, to avoid accidents involving technicians in charge of handling.

According to Dr. Placeres, samples are taken only from persons with suspicious clinical and epidemiological signs; that is, from people who have arrived from countries affected by the virus and who present symptoms associated with the disease, and those with whom they have had sustained contact.

The IPK director added that samples are taken between the first and seventh day of symptoms, with the most effective period being between the third and fifth day. In addition, he said, the most common drugs used with patients thus far are antiretrovirals and Oseltamivir, also used to combat influenza.

Regarding training being provided by the IPK, Dr. José Luis Aparicio Suárez, head of the Ministry of Public Health's Postgraduate Department, described the work as "a continuous, sequential process, targeting specific groups, according to their profession or occupation. The courses we give are for those who can use the knowledge, which includes directors of the country's main medical institutions, epidemiologists, pediatric and adult intensive care specialists, and others," he said.

Dr. Aparicio explained that professionals being trained serve as facilitators, sharing what they learn in their home territories, ensuring that information, and protocols to be followed, are extended not only to personnel in the Cuban health system, but to the general population, as well.

In this regard, Dr. Guadalupe Guzmán, head of the IPK's Research, Diagnostic and Reference Center, said that thousands of workers in the national health system and also personnel from other sectors have received training on the new coronavirus, which serves to support implementation of the national Covid-19 control and prevention plan.

This effort makes use of the existing network of medical schools and reaches community family doctors' offices - the basic unit of our health system. Likewise, social and mass organizations are holding health hearings and educational talks at workplaces and in neighborhoods, to ensure that all citizens are informed and developing a culture of healthcare and epidemiological awareness, to fully appreciate the danger posed by Covid-19.

In context

The Pedro Kourí Institute of Tropical Medicine (IPK) was founded on December 8, 1937 by Professor Pedro Kourí Esmeja, an eminent Cuban parasitologist, to conduct research primarily in the field of parasitology and tropical medicine, in collaboration with the University of Havana's school of medicine, and based at Calixto Garcia Hospital.

Notable studies were carried out here, contributing to Dr. Kourí's international prominence in the field. Findings on the biology of the causal agent of Fasciola, its pathogenic action, diagnosis, prophylaxis and epidemiology, were among the most important.

Taking into account the growing presence of Cuban internationalists in different geographical areas of the planet, in 1979 the country's leadership called upon Dr. Gustavo Kourí Flores (Pedro Kourí's son) to assume the mission of promoting the development of what would be come to be the Pedro Kourí Institute of Tropical Medicine.

The Institute would have its first great challenge facing the national health emergency created by the dengue hemorrhagic fever epidemic in 1981, leaving158 deaths, including 101 children. Within a short period of time, researchers here were able to isolate the virus that caused the illness (dengue serotype 2), which had never before appeared in our region.

The World Health Organization (WHO) has recognized the IPK as a Collaborating Center for the Study of Dengue and its Vector, and in conjunction with the Pan American Health Organization, a Collaborating Center for the elimination of Tuberculosis.

The IPK has played a vital role in the diagnosis, prevention, control and treatment of various diseases and epidemics that have occurred in Cuba, such as the appearance of HIV/AIDS in the late 1980s - continuing to serve as the national reference center for the diagnosis and treatment of AIDS complications - as well as hemorrhagic conjunctivitis, malaria, neuropathy, viral encephalitis, leptospirosis, h1n1 influenza (2009), cholera (2012) and other dengue outbreaks over the past two decades. Cuban health brigades received intensive training at the IPK, to prepare for their work fighting the Ebola epidemic in Sierra Leone, Liberia and Guinea Conakry (2014).

On October 29, 1993, the current facility was inaugurated by Comandante en jefe Fidel Castro Ruz, who stated that day, "Please do not consider the Pedro Kourí Institute, which we inaugurate today, only as a Cuban institution, but as an institution for humanity."

Comments

Popular posts from this blog

Tapeworms: How to tell if you have one - Fox News

What Is Vitiligo? All About This Unique Skin Condition That Impacts Skin Pigmentation, and How To Treat It - Parade Magazine

The 18 Best Body Butters to Revive Your Skin for Spring - WWD